热门资讯> 正文
传奇生物发行定价后股价走高
2021-12-17 04:22
01:21 PM EST, 12/16/2021 (MT Newswires) -- Legend Biotech (LEGN) shares were up over 5% in Thursday afternoon trading after it priced its public offering of 7.5 million American depositary shares at $40 per ADS for gross proceeds of about $300 million.
Each ADS represents two ordinary shares. Underwriters have been granted a 30-day option to buy up to about 1.1 million additional ADSs. The offering is expected to close on Dec. 20.
Price: 43.38, Change: +2.24, Percent Change: +5.43
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
